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ABSTRACT:  A  silver-mediated  cross-coupling  of 
trifluoromethoxide with aryl stannanes and arylboronic acids 
to give aryl trifluoromethyl ethers is reported.  This is the first 
report  of  a  transition-metal-mediated  Caryl–OCF3  bond 
formation. 
Fluorine  incorporation  often  improves  the  properties  of 
pharmaceuticals, agrochemicals, and materials.
1 Previous research 
has resulted in the development of several trifluoromethylation
2 
and  fluorination
3  reactions  via  transition-metal-mediated  and 
catalyzed  cross-coupling  reactions.    Despite  the  utility  of 
trifluoromethoxy arenes in pharmaceuticals and agrochemicals, in 
part due to their high stability towards metabolism,
4 transition-
metal-mediated  cross-coupling  reactions  for 
trifluoromethoxylation  (Caryl–OCF3)  are  currently  unavailable.  
Difficulties in C–OCF3 bond formation can be attributed to the 
reversible decomposition of trifluoromethoxide anion in solution 
above room temperature to afford carbonic difluoride (b.p.: –84 
ºC)  and  fluoride,
5  as  well  as  β-fluoride  elimination
6  from 
transition metal–trifluoromethoxide complexes.  Earlier this year 
Buchwald  reported  a  Pd-catalyzed  Caryl–SCF3  cross  coupling 
reaction.
7  Thus  far,  the  analogous  reaction  to  make  aryl 
trifluoromethyl  ethers  has  not  been  developed  via  Pd-catalyzed 
cross-coupling, possibly due to the commonly employed reaction 
conditions involving basic media at elevated temperature typically 
used  for  challenging  C–X  bond  forming  reactions;
3n  such 
conditions may lead to decomposition of trifluoromethoxide anion 
before C–O bond formation.  Herein we report a silver-mediated 
cross-coupling  reaction  of  trifluoromethoxide  1  with  aryl 
stannanes and arylboronic acids to give aryl trifluoromethyl ethers 
(Ar–OCF3)  (Scheme  1).    The  reported  trifluoromethoxylation 
reaction  provides  access  to  several  novel  aryl  trifluoromethyl 
ethers under conditions tolerant of a variety of functional groups. 
Aryl trifluoromethyl ethers are conventionally made from phenols 
via fluoroformate or chlorothionoformate intermediates, followed 
by  nucleophilic  fluorination  with  antimony  trifluoride, 
hydrofluoric acid, or sulfur tetrafluoride at 100 °C to 160 °C.
8 
Only  structurally  simple  phenol  derivatives  can  tolerate  such 
reaction  conditions.    Togni  and  coworkers  have  reported  the 
successful trifluoromethylation of primary and secondary alcohols 
with electrophilic hypervalent iodine reagents.
9 Similar attempts 
to  trifluoromethylate  2,4,6-trimethylphenol  afforded  products 
primarily  resulting  from  carbon  trifluoromethylation  and  up  to 
15% yield of the desired aryl trifluoromethoxy ether.
10 Umemoto 
and  coworkers  have  reported  trifluoromethylation  of  phenols 
using  O-(trifluoromethyl)-dibenzofuranium  salts  under  photo-
irradiation  at  −100  °C.
11  And  Kolomeitsev  has  reported  the 
synthesis  of  phenyl  and  naphthyl  trifluoromethyl  ether  via 
addition of trifluoromethoxide to in situ generated benzyne and α-
naphthyne, respectively.
5a 
Here  we  report  a  new  strategy  for  the  synthesis  of  aryl 
trifluoromethyl ethers: trifluoromethoxylation of aryl nucleophiles 
by  Caryl–O  bond  formation.  Treatment  of  aryl  stannanes  with 
trifluoromethoxide  1,  F-TEDA-PF6 ( 4),  and  silver(I) 
hexafluorophosphate (AgPF6) in a THF/acetone mixture at −30 °C 
afforded the desired aryl trifluoromethyl ethers in 59–88% yield 
(Table 1).  Reagent 1 was prepared in situ from trifluoromethyl 
trifluoromethanesulfonate,  a  non-fuming,  hydrolytically  stable 
liquid that is commercially available and synthesized from triflic 
acid  in  one  step  (see  Supporting  Information)  and 
tris(dimethylamino)sulfonium  difluorotrimethylsilicate  (TASF).  
The  trifluoromethoxylation  reaction  tolerates  functional  groups 
like alcohols, halogens, esters, ethers, alkenes, and ketones and 
can  be  applied  to  electron-rich,  electron-poor,  and  ortho-
substituted  arenes.    Trifluoromethoxylation  can  also  be 
accomplished from arylboronic acids (Table 2).  While in general 
arylboronic acids are preferred reagents over aryltin reagents, a 
two-step,  one-pot  procedure  is  required  for  the  presented 
trifluoromethoxylation  of  arylboronic  acids.    Treatment  of 
arylboronic acids with sodium hydroxide in methanol followed by 
AgPF6  gave  the  corresponding  aryl  silver  complexes,  which 
afforded aryl trifluoromethyl ethers upon addition of 1 and 4 in a 
THF/acetone solvent mixture.  Currently, aryl nucleophiles (both 
arylboronic  acids  and  aryl  stannanes) containing  basic  nitrogen 
functional groups such as pyridine afford trifluoromethyl ethers in 
substantially lower yield.  For example, trifluoromethoxylation of 
6-(tributylstannyl)quinoline  gives  6-(trifluoromethoxy)quinoline 
in 16% yield. 
Scheme 1. Trifluoromethoxylation. 
 
Both trifluoromethoxide salt and solvent have a significant impact 
on  the  yield  of  trifluoromethoxylation.    Deviation  from  the 
reaction  conditions  described  in  Table  1  leads  to  byproducts, 
which  result  from  fluorodestannylation,  hydroxydestannylation, 
protodestannylation, and biaryl formation via homocoupling in up 
to 50% combined yield.  Byproduct formation was minimized by 
reaction optimization (see Supporting Information), but remains 
challenging  for  some  substrates.    For  example, 
trifluoromethoxylation  of  morphine  derivative  25,  the  substrate 
that affords the lowest yield among the examples shown in Table 
1, gave 24% of the corresponding fluorodestannylated and 10% 
the  corresponding  protodestannylated  product,  respectively.  
Byproducts  could  be  separated  in  all  cases  by  column 
chromatography. 
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Table 1. Trifluoromethoxylation of Aryl Stannanes 
 
substrate  product  yield [%] 
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Table  2.  Trifluoromethoxylation  of  Arylboronic 
Acids.
 
substrate  product  yield (%) 
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72 
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6 
63 
 
29 
 
18 
76 
 
30 
 
31 
64 
 
32 
 
33 
65 
 
34 
 
35 
67
a 
a)  Yield  was  determined  by 
19F  NMR  with  3-nitrofluorobenzene  as 
internal standard. 
The  ability  to  form  carbon–heteroatom  bonds  at  a  lower 
temperature than usually employed for challenging C–heteroatom 
cross  coupling  reactions
3n,7  was  key  to  the  development  of 
trifluoromethoxylation  because  irreversible  fluoride  dissociation 
from trifluoromethoxide could be prevented.  The ability to effect 
challenging carbon–heteroatom bond transformations from silver 
complexes  may  be  a  consequence  of  synergistic  metal–metal 
interactions  that  can  lower  activation  barriers,  as  identified  for 
bimetallic catalysis.
12 We hypothesize that trifluoromethoxylation 
proceeds from discrete high-valent silver complexes, formed via 
oxidation  of  aryl  silver  complexes  with  F-TEDA-PF6 ( 4), 
followed by fluoride to trifluoromethoxide ligand exchange.  The 
use of two equivalents of AgPF6 gave the highest observed yields 
of trifluoromethoxylation, which could suggest a dinuclear silver 
complex  as  a  key  intermediate  in  C–OCF3  bond  formation.  
Bimetallic silver redox behavior has previously been proposed for 
the  Ag-mediated  fluorination  of  aryl  stannanes.
3j,o,r  In  the 
fluorination  reaction,  catalysis  could  be  achieved  but  required 
heating to 65 °C.  A similar approach to achieve silver catalysis 
for trifluoromethoxylation was not successful, presumably due to 
the thermal instability of trifluoromethoxide. 
In  conclusion,  a  Ag-mediated  trifluoromethoxylation  of 
functionalized  aryl  stannanes  and  arylboronic  acids  is  reported.   
 
3 
The inability to efficiently trifluoromethoxylate arenes with basic 
functional  groups  such  as  amines  and  pyridines  is  currently  a 
limitation  of  the  reaction.    In  addition,  the  necessity  for  toxic 
arylstannanes and the two-step procedure from arylboronic acids 
currently  limit  the  practicality  of  the  presented 
trifluoromethoxylation  reaction.    Currently,  however,  no  other 
method is available to trifluoromethoxylate aryl nucleophiles via 
cross coupling.  We have addressed the fundamental challenges 
associated  with C aryl–OCF3  bond  formation  via  silver  redox 
chemistry.  Future efforts in the field should be directed at the 
development of more practical reactions with broader functional 
group tolerance. 
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